Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer, Novartis Learning The VALUE Of Comparative Research

Executive Summary

A Novartis-sponsored study comparing Diovan to Pfizer's Norvasc highlights the risk firms take in conducting comparative research

You may also be interested in...



CMS, Industry To Debate “Practical” Trials On July 20 Audio Conference

The benefits and pitfalls of "practical clinical trials" for drugs and devices will be debated during a July 20 Drug & Device Dialogue 1audio conference

CMS, Industry To Debate “Practical” Trials On July 20 Audio Conference

The benefits and pitfalls of "practical clinical trials" for drugs and devices will be debated during a July 20 Drug & Device Dialogue 1audio conference

AHRQ Comparative Study Agenda Should Emphasize Lit Reviews – McClellan

The federal government's investment in comparative effectiveness research for drugs should emphasize literature reviews and other alternatives to clinical trials, Centers for Medicare & Medicaid Services Administrator Mark McClellan said

Related Content

UsernamePublicRestriction

Register

LL1135972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel